Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab for multiple sclerosis.
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Monomethylfumarate reduces in vitro migration of mononuclear cells.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Microsurgical Pontine Descending Tractotomy in Cases of Intractable Trigeminal Neuralgia.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study.
Subclinical Optic Neuritis in Neuromyelitis Optica.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
Induction and molecular signature of pathogenic T(H)17 cells.
Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.
Identifying and addressing unmet therapeutic needs in MS.
Evaluation of hemodynamic properties of cerebral venous drainage in patients with multiple sclerosis: a case-control study.
Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: Sexual dimorphism and diergism at the spinal cord level.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
New treatments for multiple sclerosis: at what long-term risk?
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
Pages
« first
‹ previous
…
369
370
371
372
373
374
375
376
377
…
next ›
last »